• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Pharmacokinetic study of domestic caspofungin compared with original caspofungin for empirical therapy in patients with persistent fever and agranulocytosis].

作者信息

Zheng X Y, Liang A B, Yang X Z, Fu J F, Hou M, Sun A N, Lu H, Jin J, Hu J D

机构信息

Department of Hematology, Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fuzhou 350001, China.

Department of Hematology, Tongji Hospital, Tongji University, Shanghai 200065, China.

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2020 Dec 14;41(12):1031-1034. doi: 10.3760/cma.j.issn.0253-2727.2020.12.011.

DOI:10.3760/cma.j.issn.0253-2727.2020.12.011
PMID:33445852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7840557/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c1c/7840557/0ae6b98709bd/cjh-41-12-1031-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c1c/7840557/0ae6b98709bd/cjh-41-12-1031-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c1c/7840557/0ae6b98709bd/cjh-41-12-1031-g001.jpg

相似文献

1
[Pharmacokinetic study of domestic caspofungin compared with original caspofungin for empirical therapy in patients with persistent fever and agranulocytosis].国产卡泊芬净与原研卡泊芬净用于持续发热和粒细胞缺乏症患者经验性治疗的药代动力学研究
Zhonghua Xue Ye Xue Za Zhi. 2020 Dec 14;41(12):1031-1034. doi: 10.3760/cma.j.issn.0253-2727.2020.12.011.
2
Economic impact of caspofungin as compared with liposomal amphotericin B for empirical therapy in febrile neutropenia in Australia.在澳大利亚，卡泊芬净与脂质体两性霉素B用于发热性中性粒细胞减少症经验性治疗的经济影响比较
J Antimicrob Chemother. 2009 Jun;63(6):1276-85. doi: 10.1093/jac/dkp119. Epub 2009 Apr 3.
3
A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia.一项卡泊芬净与两性霉素 B 脂质体用于儿童持续性发热伴中性粒细胞减少症经验性抗真菌治疗的随机、双盲、多中心研究。
Pediatr Infect Dis J. 2010 May;29(5):415-20. doi: 10.1097/INF.0b013e3181da2171.
4
Economic evaluation of caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia in Sweden.在瑞典，卡泊芬净与脂质体两性霉素B用于持续发热和中性粒细胞减少患者经验性抗真菌治疗的经济学评价
Scand J Infect Dis. 2011 Jul;43(6-7):504-14. doi: 10.3109/00365548.2011.556145. Epub 2011 Feb 18.
5
Breakthrough Hormographiella aspergillata infections arising in neutropenic patients treated empirically with caspofungin.中性粒细胞减少症患者经验性使用卡泊芬净治疗时出现突破性曲霉菌属aspergillata 感染。
J Clin Microbiol. 2011 Jan;49(1):461-5. doi: 10.1128/JCM.01213-10. Epub 2010 Nov 10.
6
Caspofungin versus liposomal amphotericin B: are they really comparable?卡泊芬净与两性霉素B脂质体：它们真的具有可比性吗？
Pediatr Infect Dis J. 2010 Oct;29(10):985-6; author reply 986-7. doi: 10.1097/INF.0b013e3181f2d878.
7
High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia.接受卡泊芬净治疗持续性发热和中性粒细胞减少的患者中侵袭性曲霉菌病突破性感染率较高。
Clin Microbiol Infect. 2010 Aug;16(8):1191-6. doi: 10.1111/j.1469-0691.2009.03050.x. Epub 2009 Sep 3.
8
Economic evaluation of caspofungin versus liposomal amphotericin B for empiric antifungal treatment in patients with neutropenic fever in Italy.意大利中性粒细胞减少性发热患者经验性抗真菌治疗中卡泊芬净与两性霉素B脂质体的经济学评价
Value Health. 2008 Sep-Oct;11(5):830-41. doi: 10.1111/j.1524-4733.2008.00324.x. Epub 2008 May 20.
9
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.卡泊芬净与两性霉素B脂质体用于持续发热和中性粒细胞减少患者的经验性抗真菌治疗比较
N Engl J Med. 2004 Sep 30;351(14):1391-402. doi: 10.1056/NEJMoa040446.
10
Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.脂质体两性霉素B：关于其在发热性中性粒细胞减少症经验性治疗及侵袭性真菌感染治疗中应用的综述
Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010.

本文引用的文献

1
Evaluation of the effectiveness of caspofungin against febrile neutropenia and the factors related to the alteration in its plasma concentration.评估卡泊芬净对发热性中性粒细胞减少症的疗效及影响其血药浓度变化的相关因素。
J Infect Chemother. 2019 Oct;25(10):801-805. doi: 10.1016/j.jiac.2019.04.011. Epub 2019 Apr 29.
2
Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysis.发热性中性粒细胞减少患者侵袭性真菌病的经验性治疗：一项系统评价和网状Meta分析。
BMC Infect Dis. 2017 Feb 20;17(1):159. doi: 10.1186/s12879-017-2263-6.
3
[Cross-sectional investigation of first-choice of antifungal agents in empirical and preemptive antifungal therapy for patients with hematological malignancies].
[血液系统恶性肿瘤患者经验性和抢先性抗真菌治疗中抗真菌药物首选的横断面调查]
Zhonghua Xue Ye Xue Za Zhi. 2013 Jun;34(6):473-7. doi: 10.3760/cma.j.issn.0253-2727.2013.06.006.
4
Weight drives caspofungin pharmacokinetic variability in overweight and obese people: fractal power signatures beyond two-thirds or three-fourths.超重和肥胖人群的体重会影响卡泊芬净的药代动力学变异性：三分之二或四分之三以上的分形幂律特征。
Antimicrob Agents Chemother. 2013 May;57(5):2259-64. doi: 10.1128/AAC.01490-12. Epub 2013 Mar 4.
5
Caspofungin: a review of its use in the treatment of fungal infections.卡泊芬净：其在真菌感染治疗中的应用综述
Drugs. 2005;65(14):2049-68. doi: 10.2165/00003495-200565140-00009.
6
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.卡泊芬净与两性霉素B脂质体用于持续发热和中性粒细胞减少患者的经验性抗真菌治疗比较
N Engl J Med. 2004 Sep 30;351(14):1391-402. doi: 10.1056/NEJMoa040446.
7
Caspofungin.卡泊芬净
Clin Infect Dis. 2003 Jun 1;36(11):1445-57. doi: 10.1086/375080. Epub 2003 May 19.
8
Caspofungin.卡泊芬净
Drugs. 2001;61(8):1121-9; discussion 1130-1. doi: 10.2165/00003495-200161080-00007.